LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 36.73 | 84.90 | 1206 | 3254 | 0.3706 | 0.6561 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 36.73 | 84.90 | 1282 | 3254 | 0.3939 | 0.6754 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 36.73 | 84.90 | 717 | 3254 | 0.2203 | 0.5002 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 36.73 | 84.90 | 1385 | 3254 | 0.4256 | 0.7002 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 38.43 | 84.90 | 1235 | 3459 | 0.3570 | 0.6497 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 38.43 | 84.90 | 1299 | 3459 | 0.3755 | 0.6653 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 38.43 | 84.90 | 892 | 3459 | 0.2578 | 0.5523 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 38.43 | 84.90 | 1469 | 3459 | 0.4246 | 0.7040 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 40.14 | 84.90 | 1252 | 3682 | 0.3400 | 0.6402 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 40.14 | 84.90 | 1302 | 3682 | 0.3536 | 0.6520 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 40.14 | 84.90 | 990 | 3682 | 0.2689 | 0.5709 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 40.14 | 84.90 | 1516 | 3682 | 0.4117 | 0.6989 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.84 | 84.90 | 1400 | 4003 | 0.3497 | 0.6556 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.84 | 84.90 | 1461 | 4003 | 0.3650 | 0.6684 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.84 | 84.90 | 1122 | 4003 | 0.2803 | 0.5910 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 41.84 | 84.90 | 1516 | 4003 | 0.3787 | 0.6795 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.55 | 84.90 | 1475 | 4287 | 0.3440 | 0.6563 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.55 | 84.90 | 1526 | 4287 | 0.3559 | 0.6662 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.55 | 84.90 | 1234 | 4287 | 0.2878 | 0.6048 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 43.55 | 84.90 | 1701 | 4287 | 0.3967 | 0.6985 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.25 | 84.90 | 1492 | 4539 | 0.3286 | 0.6476 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.25 | 84.90 | 1539 | 4539 | 0.3390 | 0.6565 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.25 | 84.90 | 1614 | 4539 | 0.3555 | 0.6703 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 45.25 | 84.90 | 1800 | 4539 | 0.3965 | 0.7023 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 46.95 | 84.90 | 1574 | 4952 | 0.3178 | 0.6450 | MN20160318_Q02 | C11 |